Abrocitinib Improved Dupilumab-Resistant Severe Atopic Dermatitis with Comorbid Mild Alopecia Areata in a 12-Year-Old Boy: A Case Report with 1-Year Follow-Up

Abrocitinib Improved Dupilumab-Resistant Severe Atopic Dermatitis with Comorbid Mild Alopecia Areata in a 12-Year-Old Boy: A Case Report with 1-Year Follow-Up

Xiaohan Liu,1– 3,* Biao Song,1– 3,* Hongzhong Jin1– 3 1Department of Dermatology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People’s Republic of China; 2State Key Laboratory of Complex Severe and Rare Disease...

Full description

Bibliographic Details
Main Authors: Liu X, Song B, Jin H
Format: Article
Language:English
Published: Dove Medical Press 2024-04-01
Series:Journal of Asthma and Allergy
Subjects:
atopic dermatitis
alopecia areata
janus kinase inhibitors
dupilumab
Online Access:https://www.dovepress.com/abrocitinib-improved-dupilumab-resistant-severe-atopic-dermatitis-with-peer-reviewed-fulltext-article-JAA

Internet

https://www.dovepress.com/abrocitinib-improved-dupilumab-resistant-severe-atopic-dermatitis-with-peer-reviewed-fulltext-article-JAA

Similar Items